ProCE Banner Activity

Ключевые исследования ВИЧ, повлиявшие на мою работу, по итогам CROI 2023

Slideset

Загрузите слайды, чтобы ознакомиться с обзорами ключевых исследований ВИЧ по итогам CROI 2023, включая результаты исследований стратегий профилактики, длительного лечения, побочных явлений ART, терапии второй линии и коинфекции.

Released: March 23, 2023

Share

Faculty

Eric S. Daar

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Joseph J. Eron Jr.

Joseph J. Eron Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Monica Gandhi

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

Princy N. Kumar

Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Babafemi Taiwo

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Supporters

This activity is supported by an educational grant from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Эрик С. Даар, доктор медицинских наук: консультант/эксперт/лектор: Gilead, GSK, Merck, Theratechnologies, ViiV; исследовательская работа: Gilead Sciences, GSK, ViiV.

Joseph J. Eron Jr., MD

Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology
Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Джозеф Дж. Эрон-младший, доктор медицинских наук: консультант/эксперт/лектор: Gilead Sciences, GlaxoSmithKline, Janssen, Merck, ViiV; исследовательская работа: Gilead Sciences, ViiV.

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

Моника Ганди, доктор медицинских наук, магистр здравоохранения (MPH), соответствующие финансовые связи не раскрываются.

Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Принси Н. Кумар, доктор медицинских наук, член Американского общества инфекционных болезней (FIDSA), член Ассоциации дипломированных мануальных терапевтов (MACP): консультант/эксперт/лектор: Johnson & Johnson, Thera, ViiV; исследовательская работа: Merck; отдельные продающиеся на бирже акции и опционы на акции: Gilead, Pfizer. 

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, MSD, ViiV; researcher: AstraZeneca, Gilead, GSK, MSD, ViiV.

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Бабафеми Тайво, бакалавр медицины и бакалавр хирургии: консультант: Gilead, GlaxoSmithKline, Johnson & Johnson, ViiV.